{"id":70705,"date":"2026-05-12T09:29:41","date_gmt":"2026-05-12T09:29:41","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70705"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"oxytocin-acetate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/oxytocin-acetate\/","title":{"rendered":"Acetato de Oxitocina"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 Acetato de Oxitocina?<\/h3>\n<p style=\"margin: 0;\"><strong>Acetato de Oxitocina<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide with a single disulfide bridge between Cys1 and Cys6. It is one of the oldest and most extensively studied neuropeptides in published studies, acting as both a hypothalamic hormone (uterine contraction, milk ejection) and a central neuromodulator of social bonding, trust, and affiliative behaviour. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">50-56-6 (oxitocina base livre); fornecido como sal de acetato<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub> (base livre; sal de acetato adiciona CH<sub>3<\/sub>Contrai\u00e3o COOH)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1007.19 Da (base livre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH<sub>2<\/sub> (CYIQNCPLG-NH<sub>2<\/sub>, 9 amino\u00e1cidos; ponte dissulfeto intramolecular Cys<sup>1<\/sup>\u2013Cys<sup>6<\/sup> formando um anel macroc\u00edclico de 6 res\u00edduos com uma cauda C-terminal de 3 res\u00edduos; extremidade C-terminal amidada)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sal de acetato liofilizado (p\u00f3 branco a branco-acinzentado)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 Acetato de Ocitocina?<\/h2>\n<p><strong>Acetato de Oxitocina<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide first isolated by Sir Henry Dale in 1906 and chemically synthesised by Vincent du Vigneaud in 1953 \u2014 the first peptide hormone ever produced by total synthesis, work that earned du Vigneaud the 1955 Nobel Prize in Chemistry. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and water solubility relative to free-base oxytocin without altering pharmacology \u2014 the acetate dissociates rapidly in physiological solution. The well-characterised sequence is CYIQNCPLG-NH<sub>2<\/sub> com uma ponte dissulfeto intramolecular entre Cys1 e Cys6 que cria um anel macroc\u00edclico de 6 res\u00edduos e uma cauda C-terminal de 3 res\u00edduos. O peso molecular \u00e9 1007.19 Da (base livre); f\u00f3rmula emp\u00edrica C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub>. Oxytocin is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For related small-peptide CNS studies, see our <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/pt-141\/\">PT-141<\/a> p\u00e1ginas de produtos. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Fun\u00e7\u00f5es End\u00f3crinas Perif\u00e9ricas e Neuromoduladoras Centrais<\/h2>\n<p>What makes oxytocin unusual among peptides is its <strong>dupla identidade<\/strong> como hormona end\u00f3crina perif\u00e9rica e neuromodulador central. A mesma mol\u00e9cula, libertada de diferentes compartimentos anat\u00f3micos, produz efeitos fisiol\u00f3gicos fundamentalmente diferentes:<\/p>\n<ul>\n<li><strong>Liberta\u00e7\u00e3o end\u00f3crina perif\u00e9rica \u2014 efeitos uterinos e mam\u00e1rios<\/strong> \u2014 A oxitocina \u00e9 sintetizada em neur\u00f3nios magnocelulares dos n\u00facleos supra\u00f3ptico e paraventricular do hipot\u00e1lamo e libertada na circula\u00e7\u00e3o sist\u00e9mica a partir da hip\u00f3fise posterior. A oxitocina perif\u00e9rica liga-se aos recetores OXTR no m\u00fasculo liso uterino (estimulando as contra\u00e7\u00f5es durante o parto) e nas c\u00e9lulas mioepiteliais dos alv\u00e9olos mam\u00e1rios (desencadeando o reflexo de eje\u00e7\u00e3o do leite). A meia-vida perif\u00e9rica \u00e9 curta (~3\u20135 minutos IV) devido ao metabolismo r\u00e1pido pela oxitocinase e outras peptidases.<\/li>\n<li><strong>Liberta\u00e7\u00e3o central \u2014 comportamento social, afiliativo e de redu\u00e7\u00e3o do stress<\/strong> \u2014 A separate population of parvocellular oxytocin neurons projects axonally into brain regions including the amygdala, nucleus accumbens, ventral tegmental area, and prefrontal cortex. Central oxytocin release does not enter systemic circulation and is not measured by plasma assays. In published studies it modulates pair-bonding, in-group affiliation, trust, fear extinction, and stress reactivity. The prairie-vole pair-bonding literature is the canonical mechanistic dataset for central oxytocin signalling.<\/li>\n<li><strong>Farmacologia do recetor e transdu\u00e7\u00e3o de sinal<\/strong> \u2014 A oxitocina atua num \u00fanico recetor acoplado \u00e0 prote\u00edna G (OXTR), que se acopla principalmente a G\u03b1<sub>q\/11<\/sub> para ativar a fosfolipase C, IP<sub>3<\/sub>, e liberta\u00e7\u00e3o de c\u00e1lcio intracelular no m\u00fasculo liso. No SNC, a sinaliza\u00e7\u00e3o OXTR \u00e9 mais complexa e inclui acoplamento G\u03b1<sub>i\/o<\/sub> coupling, modulation of GABAergic interneurons, and crosstalk with the closely-related vasopressin V1a receptor. Selective OXTR agonists and antagonists are heavily used in current studies to dissect oxytocin vs vasopressin contributions to behaviour.<\/li>\n<\/ul>\n<p>The intranasal administration route is one of the most-cited studies delivery methods because it produces measurable CNS effects on social behaviour without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism by which intranasal oxytocin reaches CNS compartments \u2014 whether through olfactory and trigeminal nerve transport, cribriform plate diffusion, or a peripheral feedback signal \u2014 remains an active studies question. The behavioural effects are reproducible enough that intranasal administration has become the standard route in human and rodent oxytocin behavioural support. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Oxytocin Acetate is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Comportamento social e forma\u00e7\u00e3o de pares<\/strong> \u2014 testes de prefer\u00eancia de parceiro em arganazes-da-pradaria, forma\u00e7\u00e3o de prefer\u00eancia de parceiro em arganazes monog\u00e2micos vs polig\u00e2micos, paradigmas de reconhecimento social em roedores (Insel &amp; Hulihan, Behav Neurosci 1995; Young &amp; Wang, Nat Neurosci 2004)<\/li>\n<li><strong>Autism spectrum and social-cognition studies<\/strong> \u2014 preclinical models of social-deficit phenotypes, OXTR variant cohort studies, intranasal oxytocin behavioural endpoints; one of the most active areas of contemporary oxytocin clinical studies<\/li>\n<li><strong>Trust and cooperation behavioural support<\/strong> \u2014 paradigmas econ\u00f3micos do jogo da confian\u00e7a, tomada de decis\u00e3o cooperativa sob incerteza; modula\u00e7\u00e3o do vi\u00e9s de grupo interno vs externo<\/li>\n<li><strong>Stress, ansiedade e extin\u00e7\u00e3o do medo<\/strong> \u2014 amygdala-dependent fear conditioning, stress-induced HPA-axis activation, cortisol response modulation in published studies<\/li>\n<li><strong>Comportamento materno e cuidados parentais<\/strong> \u2014 postpartum maternal-behaviour induction in rodents, paternal-care studies in monogamous vole species, alloparental behaviour<\/li>\n<li><strong>Reproductive physiology studies<\/strong> \u2014 uterine contractility assays, mammary myoepithelial-cell studies, labour and parturition mechanism studies<\/li>\n<li><strong>Cicatriza\u00e7\u00e3o de feridas e regenera\u00e7\u00e3o tecidular<\/strong> \u2014 OXTR expression on dermal fibroblasts and keratinocytes; emerging studies on local oxytocin signalling in cutaneous wound repair<\/li>\n<li><strong>Comparative neuropeptide studies<\/strong> \u2014 compara\u00e7\u00e3o com vasopressina (neuropept\u00eddeo c\u00edclico de 9-aa intimamente relacionado com uma diferen\u00e7a de um amino\u00e1cido) e com outros pequenos pept\u00eddeos ativos no SNC, como <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a>.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo sobre onde a oxitocina se enquadra na paisagem dos neuromoduladores de pequenos pept\u00eddeos, consulte <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> (heptapept\u00eddeo ansiol\u00edtico), <a href=\"https:\/\/medsbase.com\/pt-pt\/pt-141\/\">PT-141<\/a> (agonista de melanocortina ativo no SNC), e <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> (heptapept\u00eddeo nootr\u00f3pico). Navegue pela <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>For\u00e7as e Concentra\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>MedsBase stocks Oxytocin Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">For\u00e7a do frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, intranasal-vehicle formulation, behavioural-test protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle studies, lowest per-mg cost, multi-cohort behavioural studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Because oxytocin&#8217;s dose range is in the low-microgram-per-administration regime, a single 5\u00a0mg vial supports many weeks of behavioural support at typical intranasal doses (24\u00a0IU \u2248 40\u00a0mcg per administration in human studies, with rodent doses scaled lower). <\/p>\n<h2>Como Compara \u2014 Acetato de Oxitocina vs Selank<\/h2>\n<p>Oxitocina e <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> are both small CNS-active peptides used in behavioural and mood-axis studies, but they target different receptors and behavioural domains. They are sometimes compared in studies because both are intranasally bioavailable and both produce measurable behavioural effects in published rodent and human studies despite being structurally and pharmacologically unrelated. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Acetato de Oxitocina<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 amino\u00e1cidos (nonapept\u00eddeo c\u00edclico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amino\u00e1cidos (heptapept\u00eddeo linear)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Estrutura<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Macrociclo com ponte dissulfeto<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Linear com C-terminal amidado<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Recetor prim\u00e1rio<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">OXTR (acoplado \u00e0 prote\u00edna G)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">N\u00e3o cl\u00e1ssico (modula\u00e7\u00e3o GABA, BDNF)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sinal comportamental<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Vincula\u00e7\u00e3o social, confian\u00e7a, comportamento afiliativo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico, resili\u00eancia ao stress<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">24\u201340 UI (~40\u201365 mcg)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 min (IV)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201330 min (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso cl\u00ednico aprovado<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Indu\u00e7\u00e3o do parto, hemorragia p\u00f3s-parto<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiol\u00edtico (apenas na R\u00fassia)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For behavioural-stacking, the two peptides have non-overlapping mechanisms (oxytocin acts on its own GPCR; Selank acts via GABA\/BDNF modulation), so co-administration is not pharmacologically redundant. Study protocols studying stress and social behaviour as joint endpoints sometimes use both arms. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazenar os frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para stock de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congelar a \u221220 \u00b0C. A oxitocina acetato liofilizada \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o at\u00e9 24 meses e a \u221220 \u00b0C at\u00e9 36 meses. Evitar ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. A forma de sal acetato \u00e9 mais higroscopicamente est\u00e1vel do que a base livre, mas os frascos devem ainda ser protegidos da humidade atmosf\u00e9rica. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 5.0\u00a0mL of bacteriostatic water yields a 1\u00a0mg\/mL working concentration; 0.04\u00a0mL delivers a 40\u00a0mcg dose (~24\u00a0IU). Swirl gently \u2014 do <strong>n\u00e3o<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazenar refrigerado a 2\u20138 \u00b0C e utilizar no prazo de 30 dias para estabilidade \u00f3tima. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do pept\u00eddeo e perturbam a liga\u00e7\u00e3o dissulfeto Cys1\u2013Cys6. Descartar qualquer frasco que apresente turva\u00e7\u00e3o, precipitado ou descolora\u00e7\u00e3o. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is Oxytocin Acetate used for in studies?<\/h3>\n<p>Oxytocin Acetate is used in studies investigating social behaviour and pair-bonding, autism spectrum and social cognition, trust and cooperation paradigms, stress and fear extinction, maternal and parental care, reproductive physiology, and wound healing. It is one of the most extensively studied neuropeptides in the published literature and serves as the canonical OXTR-axis compound. The pharmaceutical-grade oxytocin acetate sold here is <strong>n\u00e3o<\/strong> FDA-approved for non-clinical human use and is supplied strictly for clinical studies. <\/p>\n<h3>Qual \u00e9 a diferen\u00e7a entre o acetato de ocitocina e a ocitocina em base livre?<\/h3>\n<p>The acetate counterion does not alter pharmacology \u2014 it dissociates rapidly in physiological solution. The acetate salt is used in pharmaceutical-grade peptide lyophilization because it improves long-term peptide stability, reduces hygroscopicity, and improves aqueous solubility relative to free-base oxytocin. All published behavioural and endocrine effects of oxytocin apply to the acetate salt at equivalent oxytocin content. <\/p>\n<h3>Como \u00e9 que a Ocitocina difere do Selank?<\/h3>\n<p>Both are small CNS-active peptides used in behavioural support, but they target different receptors and behavioural domains. Oxytocin is a 9-amino-acid disulfide-bridged macrocyclic peptide that binds the OXTR G-protein-coupled receptor, with primary signal in social bonding and trust paradigms. Selank is a 7-amino-acid linear heptapeptide that acts via GABA modulation and BDNF expression, with primary signal in anxiolysis and stress resilience. The two are pharmacologically unrelated. <\/p>\n<h3>What is the typical Oxytocin dose?<\/h3>\n<p>Published human intranasal protocols typically use 24\u201340\u00a0IU per administration (1\u00a0IU \u2248 1.7\u00a0mcg, so 24\u00a0IU \u2248 40\u00a0mcg). Rodent doses are scaled lower in absolute mass but higher in mg\/kg. A 5\u00a0mg vial reconstituted with 5.0\u00a0mL bacteriostatic water yields 1\u00a0mg\/mL \u2014 40\u00a0mcg per 0.04\u00a0mL. <\/p>\n<h3>O Acetato de Ocitocina \u00e9 aprovado pela FDA?<\/h3>\n<p>Pharmaceutical injectable oxytocin (Pitocin, Syntocinon) is FDA-approved for specific obstetric indications \u2014 labour induction, postpartum haemorrhage control, and milk-letdown facilitation \u2014 manufactured to GMP standards by approved pharmaceutical manufacturers. <\/p>\n<h3>Como deve ser armazenado o Acetato de Ocitocina?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para stock de trabalho a curto prazo, ou \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, utilizar no prazo de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam o pept\u00eddeo e podem perturbar a ponte dissulfeto. Proteger da luz direta em todos os momentos. <\/p>\n<h3>Como reconstituir o Acetato de Ocitocina?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agite o frasco vigorosamente \u2014 a agita\u00e7\u00e3o vigorosa pode perturbar a liga\u00e7\u00e3o dissulfureto. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 l\u00edmpida e incolor. Para um frasco de 5 mg + 5,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 1 mg\/mL. <\/p>\n<h3>Que dosagens est\u00e3o dispon\u00edveis na MedsBase?<\/h3>\n<p>MedsBase carries Oxytocin Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Oxytocin be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is one of the most-cited studies delivery routes for oxytocin behavioural studies. Intranasal oxytocin produces measurable CNS effects on social behaviour, trust, and stress reactivity without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism of CNS access remains an active studies question (olfactory and trigeminal nerve transport, cribriform plate diffusion, or peripheral feedback). Subcutaneous and intracerebroventricular routes are also documented in rodent studies. <\/p>\n<h3>Qual \u00e9 a meia-vida da oxitocina?<\/h3>\n<p>In published studies, oxytocin has a plasma half-life of approximately 3\u20135 minutes following intravenous administration. The short peripheral half-life is due to rapid metabolism by oxytocinase (also called cystinyl aminopeptidase) and other peptidases. Behavioural effects following intranasal administration outlast plasma clearance because central oxytocin compartments are distinct from peripheral circulation. <\/p>\n<h3>Por que \u00e9 importante a ponte dissulfureto?<\/h3>\n<p>A liga\u00e7\u00e3o dissulfureto Cys1\u2013Cys6 bloqueia a oxitocina na conforma\u00e7\u00e3o c\u00edclica necess\u00e1ria para a liga\u00e7\u00e3o ao recetor. A redu\u00e7\u00e3o da liga\u00e7\u00e3o dissulfureto converte a oxitocina numa forma linear inativa \u2014 \u00e9 por isso que os procedimentos de reconstitui\u00e7\u00e3o evitam especificamente agita\u00e7\u00e3o vigorosa e ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o, que podem perturbar a ponte e degradar a atividade do p\u00e9ptido. O neurop\u00e9ptido estreitamente relacionado vasopressina tem a mesma arquitetura de ponte dissulfureto, com apenas uma diferen\u00e7a de amino\u00e1cido na posi\u00e7\u00e3o 3 (Phe na vasopressina vs Ile na oxitocina). <\/p>\n<h3>Does Oxytocin cause side reported effects?<\/h3>\n<p>The most consistent finding in oxytocin is dose-dependence of behavioural effects \u2014 the response is not monotonic at high doses, and very large doses can produce paradoxical effects. Acute peripheral effects can include uterine contraction (relevant in pregnancy study models) and modest vasoactive effects at supraphysiological doses. Long-term behavioural support has reported context-dependent effects \u2014 e.g., increased in-group affiliation can be accompanied by increased out-group bias in some social-cognition paradigms. <\/p>\n<h3>How long does Oxytocin take to show effects in preclinical studies?<\/h3>\n<p>Acute behavioural effects on social-recognition, partner-preference, and trust-game paradigms are detectable within 30\u201360 minutes of intranasal administration in human and rodent studies. Peripheral effects (uterine contraction, milk-ejection) occur within seconds of intravenous administration due to direct OXTR coupling to PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> . <\/p>\n<h3>Posso encomendar Acetato de Oxitocina para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia Acetato de Oxitocina para todo o mundo a partir da nossa rede dedicada de envio de p\u00e9ptidos. As encomendas exclusivas de p\u00e9ptidos qualificam-se para o nosso servi\u00e7o de envio de p\u00e9ptidos aut\u00f3nomo. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura com rastreio completo e est\u00e3o cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for CNS, Behavioural, and Affective Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/pt-pt\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Heptapept\u00eddeo nootr\u00f3pico desenvolvido na R\u00fassia \u2014 modula\u00e7\u00e3o melanocortina e dopamin\u00e9rgica<\/li>\n<li><a href=\"\/pt-pt\/pt-141\/\"><strong>PT-141 (Bremelanotide)<\/strong><\/a> \u2014 Melanocortin receptor agonist \u2014 CNS-active small peptide for sexual-behaviour studies<\/li>\n<li><a href=\"\/pt-pt\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore CNS-active peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos relacionados incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/selank\/\">Selank<\/a> for anxiolytic GABA-axis studies, <a href=\"https:\/\/medsbase.com\/pt-pt\/semax\/\">Semax<\/a> for nootropic melanocortin-axis studies, and <a href=\"https:\/\/medsbase.com\/pt-pt\/pt-141\/\">PT-141<\/a> for melanocortin sexual-behaviour studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Neuropept\u00eddeo c\u00edclico de 9 amino\u00e1cidos<br \/>\n\u2705 Agonista do recetor OXTR<br \/>\n\u2705 Social-bonding &amp; affiliative behavioural support<br \/>\n\u2705 Pept\u00eddeo com biodisponibilidade intranasal<br \/>\n\u2705 Forma de sal de acetato \u2014 maior estabilidade<\/p>\n<p><strong>Acetato de Oxitocina<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70970,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6274,5441],"class_list":["post-70705","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-oxytocin","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70970"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70705"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70705"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70705"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}